{
    "2019-12-16": [
        [
            {
                "time": "",
                "original_text": "天坛生物(600161.SH)：「人凝血酶原复合物」临床试验申报获受理",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "人凝血酶原复合物",
                        "临床试验",
                        "申报受理"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "天坛生物：下属公司获得药品临床试验申报受理",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "下属公司",
                        "药品",
                        "临床试验",
                        "申报受理"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}